Pharmaceutical Technology

The beginning of the end: Eliquis sales forecast to plummet as EU patent expiry nears

This year, sales of Eliquis (apixaban) are projected to decline by 15.2% due to the loss of its European market exclusivity ...
The Cardiology Advisor

Apixaban Linked to Higher Gastrointestinal Bleed Risk Than Aspirin in SCAF

While apixaban was linked to more total major bleeds, rates of fatal and intracranial hemorrhage were similar to aspirin.

Dr. Roach: Weighing whether or not to add a 'do not resuscitate' clause

I am an 80-year-old man in reasonably good health. The only medications that I take are Eliquis for atrial fibrillation, ...
Panola Watchman

To Your Good Health: Prognosis for patient with ‘wet brain’ doesn’t look promising

How is “wet brain” (or Wernicke encephalopathy, WE) diagnosed? My son has been in the hospital, a rehab facility, and now an assisted living facility. Is there […] ...

Dear Doctor: Is Eliquis the reason I have bruises on my legs that do not go away?

DEAR DR. ROACH: I am an 80-year-old female on Eliquis who has many bruises on her legs that do not go away. Is there a remedy ...

Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy

Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an analysis of PFE stock now.
Yahoo

Lower Prices For Eliquis, Januvia, And 8 Other Drugs Now Active For Medicare Enrollees

(The Center Square) – Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday. How much those savings will be passed on to Medicare Part D and applicable Advantage ...